Impact of Carbetocin Administration on Heart Rate When Given as an Infusion Versus as a Bolus.
Status:
Completed
Trial end date:
2021-01-15
Target enrollment:
Participant gender:
Summary
Prospective, randomized and controlled study who will be conducted at Maisonneuve-Rosemont
hospital with the following objectives:
To determine if an infusion of carbetocin over 10 minutes will reduce hemodynamic side
effects, especially the peak of heart rate, in comparison to a rapid intravenous bolus (less
than 2 seconds).
To determine if an infusion of carbetocin will reduce the other side effects of duratocin in
comparison to a rapid intravenous bolus.
Study plans to enroll 70 adult patients scheduled to undergo elective cesarean delivery under
spinal anesthesia.
Half of the patient will receive Carbetocin 100 mcg intravenous as a bolus (less than 2
seconds) and the other half will receive Carbetocin 100 mcg intravenous infusion over 10
minutes.